Innoviva Specialty Therapeutics develops and delivers innovative therapies for patients in critical care and infectious disease We are uniquely positioned to combat serious conditions and advance …

Committed to delivering the best possible solutions to patients and providers in critical care and infectious disease, we’ve developed a range of differentiated products that address major unmet …

Innoviva Specialty Therapeutics today announced that it will deliver data from six presentations at IDWeek 2025, including clinical data, and microbiologic surveillance data.

If you have a question about an Innoviva Specialty Therapeutics product and would like to speak with a medical information specialist, please call 1-800-651-3861 (Monday to Friday, 9 AM to 5 PM ET, …

Led by a mission-driven team, Innoviva Specialty Therapeutics blends rigorous medical science with proven industry experience Mr. Basso brings more than 30 years of experience of financial …

Oct 20, 2025 · “The results from all three presentations show that zoliflodacin mechanism of action is differentiated from fluoroquinolones with cure rates remaining high in the face of antibiotic …

Nov 19, 2025 · A subsidiary of Innoviva, Inc. Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com Privacy Policy | Terms of Use Team …

Nov 19, 2025 · A subsidiary of Innoviva, Inc. Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com Privacy Policy | Terms of Use Team …

May 20, 2025 · Innoviva is a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a …

Aug 13, 2025 · Since its founding in 2022, Innoviva Specialty Therapeutics, Inc. has commercialized four therapies within its critical care and infectious disease portfolio, including the two nominated …